NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction-Reference-Cited by-同舟云学术

NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction

Published:2010-05 Issue:5 Volume:16 Page:565-586
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Miller Jeffrey S.,Warren Edus H.,van den Brink Marcel R.M.,Ritz Jerome,Shlomchik Warren D.,Murphy William J.,Barrett A. John,Kolb Hans Jochem,Giralt Sergio,Bishop Michael R.,Blazar Bruce R.,Falkenburg J.H. Frederik

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference183 articles.

1. Central memory and effector memory T cell subsets: function, generation, and maintenance;Sallusto;Annu Rev Immunol,2004

2. Intrinsic and extrinsic control of effector T cell survival and memory T cell development;Hand;Immunol Res,2009

3. Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease;Chen;Blood,2004

4. Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease;Zheng;Blood,2008

5. Central memory CD8+ T cells induce graft-versus-host disease and mediate graft-versus-leukemia;Zheng;J Immunol,2009

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation;Expert Review of Hematology;2023-11-06

2. T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation;NAGOYA J MED SCI;2023

3. Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML relapse;Frontiers in Immunology;2022-10-05

4. New hope to prevent ALL relapse after transplant;Blood;2022-04-28

5. Promiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-Reactivity;Frontiers in Immunology;2022-02-16